- Home
- Publications
- Publication Search
- Publication Details
Title
Genomics and Drug Response
Authors
Keywords
-
Journal
NEW ENGLAND JOURNAL OF MEDICINE
Volume 364, Issue 12, Pages 1144-1153
Publisher
New England Journal of Medicine (NEJM/MMS)
Online
2011-03-24
DOI
10.1056/nejmra1010600
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Carbamazepine-Induced Toxic Effects and HLA-B*1502 Screening in Taiwan
- (2011) Pei Chen et al. NEW ENGLAND JOURNAL OF MEDICINE
- HLA-A*3101 and Carbamazepine-Induced Hypersensitivity Reactions in Europeans
- (2011) Mark McCormack et al. NEW ENGLAND JOURNAL OF MEDICINE
- Adjuvant therapy for postmenopausal women with endocrine-sensitive breast cancer
- (2010) Rachel A. Freedman et al. BREAST
- Adjuvant aromatase inhibitor therapy: Outcomes and safety
- (2010) Wolfgang Janni et al. CANCER TREATMENT REVIEWS
- Assessing the Clinical Utility of Diagnostics Used in Drug Therapy
- (2010) J Woodcock CLINICAL PHARMACOLOGY & THERAPEUTICS
- Reduced-Function CYP2C19 Genotype and Risk of Adverse Clinical Outcomes Among Patients Treated With Clopidogrel Predominantly for PCI
- (2010) Jessica L. Mega et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Clopidogrel and the Reduced-Function CYP2C19 Genetic Variant
- (2010) Valentin Fuster et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Genome-Wide Associations and Functional Genomic Studies of Musculoskeletal Adverse Events in Women Receiving Aromatase Inhibitors
- (2010) James N. Ingle et al. JOURNAL OF CLINICAL ONCOLOGY
- The Long and Winding Road to Warfarin Pharmacogenetic Testing**Editorials published in the Journal of the American College of Cardiologyreflect the views of the authors and do not necessarily represent the views of JACCor the American College of Cardiology.
- (2010) Geoffrey S. Ginsburg et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Warfarin Genotyping Reduces Hospitalization Rates
- (2010) Robert S. Epstein et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- ACCF/AHA Clopidogrel Clinical Alert: Approaches to the FDA “Boxed Warning”
- (2010) David R. Holmes et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Effect of CYP2C19 and ABCB1 single nucleotide polymorphisms on outcomes of treatment with ticagrelor versus clopidogrel for acute coronary syndromes: a genetic substudy of the PLATO trial
- (2010) Lars Wallentin et al. LANCET
- The human genome at ten
- (2010) NATURE
- Multiple personal genomes await
- (2010) J. Craig Venter NATURE
- Has the revolution arrived?
- (2010) Francis Collins NATURE
- Ten Years On — The Human Genome and Medicine
- (2010) Harold Varmus NEW ENGLAND JOURNAL OF MEDICINE
- Genomewide Association Studies and Assessment of the Risk of Disease
- (2010) Teri A. Manolio NEW ENGLAND JOURNAL OF MEDICINE
- Genomic Medicine — An Updated Primer
- (2010) W. Gregory Feero et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effects ofCYP2C19Genotype on Outcomes of Clopidogrel Treatment
- (2010) Guillaume Paré et al. NEW ENGLAND JOURNAL OF MEDICINE
- Inhibition of Mutated, Activated BRAF in Metastatic Melanoma
- (2010) Keith T. Flaherty et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pharmacogenetics of coumarinic oral anticoagulants
- (2010) Vangelis G Manolopoulos et al. PHARMACOGENOMICS
- VKORC1,CYP2C9andCYP4F2genetic-based algorithm for warfarin dosing: an Italian retrospective study
- (2010) Carlo-Federico Zambon et al. PHARMACOGENOMICS
- A genome-wide association study of acenocoumarol maintenance dosage
- (2009) Martina Teichert et al. HUMAN MOLECULAR GENETICS
- Association of Cytochrome P450 2C19 Genotype With the Antiplatelet Effect and Clinical Efficacy of Clopidogrel Therapy
- (2009) Alan R. Shuldiner JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- CYP4F2 Is a Vitamin K1 Oxidase: An Explanation for Altered Warfarin Dose in Carriers of the V433M Variant
- (2009) M. G. McDonald et al. MOLECULAR PHARMACOLOGY
- Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance
- (2009) Dongliang Ge et al. NATURE
- HLA-B*5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin
- (2009) Ann K Daly et al. NATURE GENETICS
- Interferon-alfa, interferon-λ and hepatitis C
- (2009) Thomas R O'Brien NATURE GENETICS
- IL28B is associated with response to chronic hepatitis C interferon-α and ribavirin therapy
- (2009) Vijayaprakash Suppiah et al. NATURE GENETICS
- Genome-wide association of IL28B with response to pegylated interferon-α and ribavirin therapy for chronic hepatitis C
- (2009) Yasuhito Tanaka et al. NATURE GENETICS
- Estimation of the Warfarin Dose with Clinical and Pharmacogenetic Data
- (2009) NEW ENGLAND JOURNAL OF MEDICINE
- Interleukin-17 and Type 17 Helper T Cells
- (2009) Pierre Miossec et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Genome-Wide Association Study Confirms VKORC1, CYP2C9, and CYP4F2 as Principal Genetic Determinants of Warfarin Dose
- (2009) Fumihiko Takeuchi et al. PLoS Genetics
- Analysis of IL-10, IL-4 and TNF-α polymorphisms in drug-induced liver injury (DILI) and its outcome
- (2008) Ketevan Pachkoria et al. JOURNAL OF HEPATOLOGY
- HLA-B*5701 Screening for Hypersensitivity to Abacavir
- (2008) Simon Mallal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cytochrome P-450 Polymorphisms and Response to Clopidogrel
- (2008) Jessica L. Mega et al. NEW ENGLAND JOURNAL OF MEDICINE
- Carbamazepine,HLA-B*1502and risk of Stevens–Johnson syndrome and toxic epidermal necrolysis: US FDA recommendations
- (2008) P Brent Ferrell et al. PHARMACOGENOMICS
- 2007 Focused Update of the ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention
- (2007) Spencer B. King et al. CIRCULATION
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation